FDA News

Latest News

US FDA Logo in Black over a White background. | Credit: US Food and Drug Administration
Fluticasone Propionate (XHANCE) Receives FDA Approval for Chronic Rhinosinusitis

March 15th 2024

On March 15, 2024, the FDA approval of fluticasone propionate nasal spray marks the first approval in agency history for treatment of chronic rhinosinusitis without nasal polyps.

FDA black and white logo | Credit: US Food and Drug Administration
Resmetirom (Rezdiffra) Receives Historic FDA Approval for Noncirrhotic NASH

March 14th 2024

Saeed Mohammed, MD, MS | Credit: Vanderbilt University Medical Center
FDA Approval of Maralixibat for Cholestatic Pruritus in PFIC Signals New Frontier for IBAT Inhibitor

March 13th 2024

Johnson & Johnson Submits Guselkumab Application to FDA for Ulcerative Colitits
Johnson & Johnson Submits Guselkumab Application to FDA for Ulcerative Colitits

March 11th 2024

US FDA logo in black over a white background. | Credit: US Food and Drug Administration
Alirocumab Approved for Heterozygous Familial Hypercholesterolemia in Patients 8 Years and Older

March 11th 2024

Video Interviews
Podcasts
Thumbnail featuring podcast hosts and logo for Diabetes Dialogue

More News

© 2024 MJH Life Sciences

All rights reserved.